One major area of advancement is the development of minimally invasive procedures to treat blocked or damaged blood vessels.

Sugar substitutes, substance abuse, GLP-1 drugs, and the biggest clinical trials of the year—each had their place in our top ...

The year saw much-anticipated data on the value of early TAVI vs surveillance, plus two new tricuspid device approvals.